Morris Barocas

Statistics

Publications

Citations

375

H-Index

Active since

2018

Affiliations

Takeda (United States)(Current)

University of California San Diego

Deerfield (United States)

Lenox Hill Hospital

North Shore University Hospital

Morris Barocas is an author at Takeda (United States) specializing in clinical remission, inflammatory bowel disease therapy, and inflammatory bowel disease.

Publications per year

2018–2019

Publications

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Neeraj Narula, Farhad Peerani, Joseph Meserve et al. · The American Journal of Gastroenterology · 2018 · 175 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation

Mark T. Osterman, Maria Rosario, Karen Lasch et al. · Alimentary Pharmacology & Therapeutics · 2019 · 88 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease

Eugenia Shmidt, Gursimran Kochhar, Justin Hartke et al. · Inflammatory Bowel Diseases · 2018 · 76 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis

William J. Sandborn, Jean–Frédéric Colombel, Remo Panaccione et al. · Journal of Crohn s and Colitis · 2018 · 36 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +14

1–4 of 4